Literature DB >> 31174953

Dysbiosis of gut microbiota in a selected population of Parkinson's patients.

Daniele Pietrucci1, Rocco Cerroni2, Valeria Unida1, Alessio Farcomeni3, Mariangela Pierantozzi2, Nicola Biagio Mercuri4, Silvia Biocca5, Alessandro Stefani6, Alessandro Desideri7.   

Abstract

INTRODUCTION: In recent years the hypothesis that gut microbiota associates with Parkinson's disease (PD) has gained importance, although it has not been possible to define a specific microbiota composition as a predictive biomarker of this disease. We have investigated dysbiosis of gut microbiota in a selected population of PD patients from Central Italy, and examined the weight of specific confounders and predictors, in order to identify potential correlations with clinical phenotypes.
METHODS: 152 fecal samples were collected from 80 patients and 72 healthy controls. Patients were enrolled according to tight inclusion criteria. Microbiota composition was studied through 16s ribosomal RNA gene amplicon sequencing analysis in combination with data on dietary/life habits. Age, loss of weight, and sex were recognized as confounding factors, whereas PD-status, age, Body Mass Index, "eat cereals", "gain of weigth" and "physical activity" as predictors. The presence of Lactobacillaceae, Enterobacteriaceae and Enterococcaceae families was significantly higher in feces from PD patients compared to healthy controls, while Lachnospiraceae were significantly reduced. Lower levels of Lachnospiraceae and higher levels of Enterobacteriaceae families also correlated with increased disease severity and motor impairment (Hoehn & Yahr stage, MDS-UPDRS Part III). Predictive metagenomics indicated a significant variation of genes involved in the metabolism of short chain fatty acids and amino acids, and in lipopolysaccharide biosynthesis.
CONCLUSIONS: PD showed a distinctive microbiota composition. Functional predictions suggest changes in pathways favoring a pro-inflammatory environment in the gastrointestinal tract, and a reduction in the biosynthesis of amino acids acting as precursors of physiological transmitters.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  16S rRNA; Dysbiosis; Functional pathways; Gut microbiota; Parkinson's disease; Predictors

Mesh:

Year:  2019        PMID: 31174953     DOI: 10.1016/j.parkreldis.2019.06.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  40 in total

Review 1.  Psychobiotics: The Next-Generation Probiotics for the Brain.

Authors:  Richa Sharma; Deesha Gupta; Rekha Mehrotra; Payal Mago
Journal:  Curr Microbiol       Date:  2021-01-04       Impact factor: 2.188

2.  Differences in Alpha Diversity of Gut Microbiota in Neurological Diseases.

Authors:  Zhuoxin Li; Jie Zhou; Hao Liang; Li Ye; Liuyan Lan; Fang Lu; Qing Wang; Ting Lei; Xiping Yang; Ping Cui; Jiegang Huang
Journal:  Front Neurosci       Date:  2022-06-28       Impact factor: 5.152

Review 3.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

Review 4.  Approaching precision medicine by tailoring the microbiota.

Authors:  Gaeun Ryu; Hyojin Kim; Ara Koh
Journal:  Mamm Genome       Date:  2021-03-01       Impact factor: 2.957

5.  The role of the microbiota-gut-brain axis in neuropsychiatric disorders.

Authors:  Jaqueline S Generoso; Vijayasree V Giridharan; Juneyoung Lee; Danielle Macedo; Tatiana Barichello
Journal:  Braz J Psychiatry       Date:  2020-07-10       Impact factor: 2.697

Review 6.  Probiotics and the Treatment of Parkinson's Disease: An Update.

Authors:  Hamed Mirzaei; Saman Sedighi; Ebrahim Kouchaki; Erfaneh Barati; Ehsan Dadgostar; Michael Aschner; Omid Reza Tamtaji
Journal:  Cell Mol Neurobiol       Date:  2021-07-20       Impact factor: 4.231

Review 7.  Does modern research validate the ancient wisdom of gut flora and brain connection? A literature review of gut dysbiosis in neurological and neurosurgical disorders over the last decade.

Authors:  Pranati Sharma; Abhishek Agrawal
Journal:  Neurosurg Rev       Date:  2021-04-26       Impact factor: 2.800

Review 8.  Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond.

Authors:  Ethan G Brown; Samuel M Goldman
Journal:  Neurotherapeutics       Date:  2020-10-09       Impact factor: 6.088

Review 9.  Gut brain axis: an insight into microbiota role in Parkinson's disease.

Authors:  Sara Ayman Moustafa; Shrouk Mohamed; Abdelhameed Dawood; Jihan Azar; Ekramy Elmorsy; Noura A M Rizk; Mohamed Salama
Journal:  Metab Brain Dis       Date:  2021-08-09       Impact factor: 3.584

10.  Identification of amyloidogenic proteins in the microbiomes of a rat Parkinson's disease model and wild-type rats.

Authors:  Line Friis Bakmann Christensen; Saeid Hadi Alijanvand; Michał Burdukiewicz; Florian-Alexander Herbst; Henrik Kjeldal; Morten Simonsen Dueholm; Daniel E Otzen
Journal:  Protein Sci       Date:  2021-06-09       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.